Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Treasury Shares (2016 - 2025)

Historic Treasury Shares for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $510214.0.

  • InfuSystem Holdings' Treasury Shares fell 1379.51% to $510214.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $510214.0, marking a year-over-year decrease of 1379.51%. This contributed to the annual value of $503894.0 for FY2024, which is 490.09% down from last year.
  • As of Q3 2025, InfuSystem Holdings' Treasury Shares stood at $510214.0, which was down 1379.51% from $511214.0 recorded in Q2 2025.
  • InfuSystem Holdings' Treasury Shares' 5-year high stood at $3.5 million during Q1 2021, with a 5-year trough of $503894.0 in Q4 2024.
  • Over the past 5 years, InfuSystem Holdings' median Treasury Shares value was $550777.5 (recorded in 2022), while the average stood at $1.3 million.
  • The largest annual percentage gain for InfuSystem Holdings' Treasury Shares in the last 5 years was 1162.84% (2025), contrasted with its biggest fall of 1379.51% (2025).
  • InfuSystem Holdings' Treasury Shares (Quarter) stood at $3.5 million in 2021, then crashed by 84.82% to $534080.0 in 2022, then decreased by 0.79% to $529862.0 in 2023, then dropped by 4.9% to $503894.0 in 2024, then increased by 1.25% to $510214.0 in 2025.
  • Its last three reported values are $510214.0 in Q3 2025, $511214.0 for Q2 2025, and $567475.0 during Q1 2025.